Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00728819 · ClinicalTrials.gov registry record · NA
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
A NA study of Venous Thrombosis, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 339
- Enrollment target
- 1
- Study location
NCT00728819 is a NA study of Venous Thrombosis that has completed, run by University of Pennsylvania. The registered enrollment target is 339 participants, below the 1,087-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00728819, a NA study of Venous Thrombosis, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 339 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two different marketed PICC (peripherally inserted central catheter) designs. Clotting rates, procedural bleeding and ease of catheter insertion will be compared. It is hypothesized that the non-tapered design has a lower clotting rate and is easier to place than the tapered design. Bleeding rates are expected to be about the same.
Conditions Studied
Interventions
- DEVICE Tapered PICC
- DEVICE Non-tapered PICC
Study Locations (1)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 339 participants |
| Start Date | 2008-08 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00728819
The ClinicalTrials.gov registry entry for NCT00728819 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 339 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,087-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (69% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Venous Thrombosis appearing as the primary indexed condition, and to 2 interventions - of which Tapered PICC is the first listed.
NCT00728819 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00728819 about?
NCT00728819 is a clinical study titled "Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters". The purpose of this study is to compare two different marketed PICC (peripherally inserted central catheter) designs. Clotting rates, procedural bleeding and ease of catheter insertion will be compared. It is hypothesized that the non-tapered design has a lower clotting rate and is easier to place t...
What is the current status of trial NCT00728819?
This trial is currently completed. It is a NA study. The enrollment target is 339 participants. The study started on 2008-08. Estimated completion is 2011-08.
What conditions does trial NCT00728819 study?
This clinical trial studies the following conditions: Venous Thrombosis.
What interventions are being tested in trial NCT00728819?
The interventions under investigation include: Tapered PICC (DEVICE), Non-tapered PICC (DEVICE).
Who is sponsoring clinical trial NCT00728819?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00728819 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
COMPLETED · NA
-
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
COMPLETED · NA
-
JETi Lower Extremity Venous Thrombosis
ACTIVE NOT RECRUITING
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.